Drug intelligence / Profile preview

Mediskin

Development stage
Unknown
Lead developer
RSL Revolutionary Labs
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Mediskin is an innovative medical-grade topical skincare formulation developed by RSL Revolutionary Labs in collaboration with Promed Bioscience. It is specifically designed to treat dermatological side effects and wounds in oncology patients undergoing cancer treatment, such as radiation-induced dermatitis and other skin toxicities. The primary active ingredient is **CollX3**, a novel water-soluble triple-helix atelocollagen complex. Mediskin works by providing a biocompatible structural scaffold that promotes wound healing and skin tissue regeneration. The project is supported by the European Union's NextGenerationEU plan and is currently being evaluated in multicenter clinical trials (e.g., NCT05588973) to assess its efficacy in wound healing and skin repair for cancer patients.

Brand names
Mediskin
Other names
mediSKIN

Beyond the preview

Go deeper on Mediskin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediskin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call